0FRI.LSE Lumibird S.A.

Healthcare Diagnostics & Research London Exchange
21.95 EUR
Close of Nov 3, 2026
18.45 28.65
Market cap
EUR 346M
P/E
124.9x
P/B
-
ROE
9.8%
Dividend yield
1.64%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is 0FRI.LSE undervalued?

Graham number

The Graham number of Lumibird S.A. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Lumibird S.A. fundamental analysis

No fundamental analysis for Lumibird S.A. yet.

Lumibird S.A. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Lumibird S.A.

Lumibird SA designs, manufactures, and sells various lasers for scientific, industrial, and medical applications in France, Hong Kong, the United States, Germany, South Korea, China, and Austria. The company operates through Photonics and Medical divisions. It offers fiber lasers and amplifiers, high power fiber lasers, and solid-state lasers, laser diodes and components; and doppler wind LiDAR, time-of-flight LiDAR and rangefinders, military laser rangefinders, and medical …

Full company profile